215 related articles for article (PubMed ID: 28400479)
1. A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer.
Lazzeroni M; Guerrieri-Gonzaga A; Gandini S; Johansson H; Serrano D; Cazzaniga M; Aristarco V; Macis D; Mora S; Caldarella P; Pagani G; Pruneri G; Riva A; Petrangolini G; Morazzoni P; DeCensi A; Bonanni B
Cancer Prev Res (Phila); 2017 Jun; 10(6):363-370. PubMed ID: 28400479
[TBL] [Abstract][Full Text] [Related]
2. A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.
Lazzeroni M; Guerrieri-Gonzaga A; Gandini S; Johansson H; Serrano D; Cazzaniga M; Aristarco V; Puccio A; Mora S; Caldarella P; Pagani G; Pruneri G; Riva A; Petrangolini G; Morazzoni P; DeCensi A; Bonanni B
Cancer Prev Res (Phila); 2016 Jan; 9(1):89-95. PubMed ID: 26526990
[TBL] [Abstract][Full Text] [Related]
3. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
4. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
Dostal AM; Samavat H; Bedell S; Torkelson C; Wang R; Swenson K; Le C; Wu AH; Ursin G; Yuan JM; Kurzer MS
Food Chem Toxicol; 2015 Sep; 83():26-35. PubMed ID: 26051348
[TBL] [Abstract][Full Text] [Related]
5. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
6. The effects of bathing in hot springs on the absorption of green tea catechin: a pilot study.
Hayasaka S; Goto Y; Maeda-Yamamoto M
Complement Ther Clin Pract; 2013 Nov; 19(4):243-5. PubMed ID: 24199981
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Lee MJ; Maliakal P; Chen L; Meng X; Bondoc FY; Prabhu S; Lambert G; Mohr S; Yang CS
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1025-32. PubMed ID: 12376503
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Lambert JD; Kim DH; Zheng R; Yang CS
J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
[TBL] [Abstract][Full Text] [Related]
9. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
[TBL] [Abstract][Full Text] [Related]
10. Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis).
Fung ST; Ho CK; Choi SW; Chung WY; Benzie IF
Br J Nutr; 2013 Jun; 109(12):2199-207. PubMed ID: 23110850
[TBL] [Abstract][Full Text] [Related]
11. Comparison of (-)-epigallocatechin-3-O-gallate (EGCG) and O-methyl EGCG bioavailability in rats.
Oritani Y; Setoguchi Y; Ito R; Maruki-Uchida H; Ichiyanagi T; Ito T
Biol Pharm Bull; 2013; 36(10):1577-82. PubMed ID: 24088254
[TBL] [Abstract][Full Text] [Related]
12. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity.
Isbrucker RA; Bausch J; Edwards JA; Wolz E
Food Chem Toxicol; 2006 May; 44(5):626-35. PubMed ID: 16364532
[TBL] [Abstract][Full Text] [Related]
13. Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.
dal Belo SE; Gaspar LR; Maia Campos PM; Marty JP
Skin Pharmacol Physiol; 2009; 22(6):299-304. PubMed ID: 19786823
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive potential of the tannase-mediated biotransformation of green tea.
Macedo JA; Ferreira LR; Camara LE; Santos JC; Gambero A; Macedo GA; Ribeiro ML
Food Chem; 2012 Jul; 133(2):358-65. PubMed ID: 25683407
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans.
Hu Y; McIntosh GH; Le Leu RK; Somashekar R; Meng XQ; Gopalsamy G; Bambaca L; McKinnon RA; Young GP
Br J Nutr; 2016 Dec; 116(11):1901-1911. PubMed ID: 27923410
[TBL] [Abstract][Full Text] [Related]
17. Electron-impact and glow-discharge ionization LC-MS analysis of green tea tincture.
Venzie JL; Castro J; Balarama Krishna MV; Nelson DM; Marcus RK
Anal Bioanal Chem; 2007 Jan; 387(1):321-33. PubMed ID: 17139484
[TBL] [Abstract][Full Text] [Related]
18. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
19. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
Lambert JD; Sang S; Hong J; Kwon SJ; Lee MJ; Ho CT; Yang CS
Drug Metab Dispos; 2006 Dec; 34(12):2111-6. PubMed ID: 16997910
[TBL] [Abstract][Full Text] [Related]
20. Effects of repeated green tea catechin administration on human cytochrome P450 activity.
Chow HH; Hakim IA; Vining DR; Crowell JA; Cordova CA; Chew WM; Xu MJ; Hsu CH; Ranger-Moore J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2473-6. PubMed ID: 17164372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
